|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02126 JW THERAP-B
Nominal 
3.070 -0.050 (-1.603%) | 2022/12 - Final RMB(¥) | %Chg (Final to Final) | 2021/12 RMB(¥) | 2020/12 RMB(¥) | 2019/12 RMB(¥) | 2018/12 RMB(¥) | ||
| Turnover | 145,702,000 | 373.105% | 30,797,000 | 0 | 0 | 0 | |
| Cost of Sales | (86,946,000) | 299.715% | (21,752,000) | -- | -- | -- | |
| Gross Profit | 58,756,000 | 549.596% | 9,045,000 | -- | -- | -- | |
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | 51,151,000 | (1,225,636,000) | (429,045,000) | (158,559,000) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (846,135,000) | 20.476% | (702,328,000) | (1,663,803,000) | (633,257,000) | (272,616,000) | |
| Taxation | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (846,135,000) | 20.476% | (702,328,000) | (1,663,803,000) | (633,257,000) | (272,616,000) | |
| Net Finance Costs / (Income) | (9,748,000) | 73.947% | (5,604,000) | (2,671,000) | (469,000) | 1,825,000 | |
| Depreciation & Amortisation | 84,810,000 | 85.791% | 45,648,000 | 23,590,000 | 17,303,000 | 5,109,000 | |
| Directors' Emoluments | -- | -- | 47,163,000 | 102,732,000 | 3,660,000 | 3,726,000 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified | |
Market Valuation Indicators
| EPS (cts) | -206.000 | -- | -176.000 | -1,261.000 | -974.000 | -- |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -1.404 | -1.979 | -2.907 | -- |
| NBV per share ($) | 5.728 | -- | 6.847 | 8.842 | -- | -- |
| Remarks: | Real time quote last updated: 05/06/2023 15:12 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -846,135,000 |
| %Change | 20.476% |
| EPS / (LPS) | RMB -2.060 |
| NBV Per Share (¥) | RMB 5.728 |